Combretastatin A4 phosphate: a novel vascular disrupting agent

Randomized phase II trial of a tumor vascular disrupting agent fosbretabulin tromethamine (CA4P) with carboplatin (C), paclitaxel (P), and bevacizumab (B) in stage IIIb/IV nonsquamous non-small cell lung cancer (NSCLC): The FALCON trial.

(2017) E. B. Garon et al.   JOURNAL OF CLINICAL ONCOLOGY

ABT-751, a novel tubulin-binding agent, decreases tumor perfusion and disrupts tumor vasculature

(2010) Yanping Luo et al.   ANTI-CANCER DRUGS

A Phase Ib trial of CA4P (combretastatin A-4 phosphate), carboplatin and paclitaxel in patients with advanced cancer

(2010) G J Rustin et al.   BRITISH JOURNAL OF CANCER

A phase IB study of ABT-751 in combination with docetaxel in patients with advanced castration-resistant prostate cancer

(2009) J. Michels et al.   ANNALS OF ONCOLOGY

Pharmacokinetics of orally administered ABT-751 in children with neuroblastoma and other solid tumors

(2009) Elizabeth Fox et al.   CANCER CHEMOTHERAPY AND PHARMACOLOGY

A Phase I Trial of Radioimmunotherapy with 131I-A5B7 Anti-CEA Antibody in Combination with Combretastatin-A4-Phosphate in Advanced Gastrointestinal Carcinomas

(2009) T. Meyer et al.   CLINICAL CANCER RESEARCH

Clinical outcome in children with recurrent neuroblastoma treated with ABT-751 and effect of ABT-751 on proliferation of neuroblastoma cell lines and on tubulin polymerization in vitro

(2009) Holly J. Meany et al.   PEDIATRIC BLOOD & CANCER

A Phase II Trial of Fosbretabulin in Advanced Anaplastic Thyroid Carcinoma and Correlation of Baseline Serum-Soluble Intracellular Adhesion Molecule-1 with Outcome

(2009) Colin J. Mooney et al.   THYROID

Randomised phase II study of ASA404 combined with carboplatin and paclitaxel in previously untreated advanced non-small cell lung cancer

(2008) M J McKeage et al.   BRITISH JOURNAL OF CANCER

Tumor blood flow interruption after radiotherapy strongly inhibits tumor regrowth

(2008) Katsuyoshi Hori et al.   CANCER SCIENCE

Phase I clinical evaluation of ZD6126, a novel vascular-targeting agent, in patients with solid tumors

(2008) Patricia M. LoRusso et al.   INVESTIGATIONAL NEW DRUGS

Medical Care in Long-Term Survivors of Childhood Cancer: A Report From the Childhood Cancer Survivor Study

(2008) Paul C. Nathan et al.   JOURNAL OF CLINICAL ONCOLOGY